Nationwide Recall Issued for Nearly 90,000 Bottles of Children’s Ibuprofen

Health officials are urging parents to check their medicine cabinets following a major nationwide recall of children’s ibuprofen. The U.S. Food and Drug Administration (FDA) has classified the move as a Class II recall, affecting nearly 90,000 bottles of the commonly used fever reducer.

The recall was initiated by Strides Pharma Inc. after the company received multiple consumer complaints regarding the presence of a foreign substance in the liquid medication. Specifically, reports described a gel-like mass and black particles found within the oral suspension.

Understanding the Risks

A Class II designation from the FDA indicates that while the probability of serious adverse health consequences is remote, exposure to the product may cause temporary or medically reversible health issues.

• Contamination Concerns: The reported black particles and gel-like mass raise significant concerns regarding product quality and safety, particularly for pediatric populations.

• Scope of Distribution: The affected 120 ml (4-fluid-ounce) bottles were distributed nationwide and manufactured for Taro Pharmaceuticals U.S.A.

• Health Advice: To date, there have been no confirmed reports of serious adverse events related to this specific recall. However, healthcare providers advise parents to stop using the medication immediately if it matches the affected lot numbers.

How to Participate in the Recall

Parents and caregivers should immediately verify the labeling on any 100 mg Children’s Ibuprofen Oral Suspension they have on hand.

• Affected Lots: The recall specifically includes Lot 7261973A and Lot 7261974A.

• Expiration Date: Both affected lots carry an expiration date of January 31, 2027.

• Next Steps: If you possess a bottle from these lots, discontinue use and contact the retailer where it was purchased for information on a refund or replacement.

• Medical Consultation: If you believe your child has already ingested medication from a recalled bottle, contact your pediatrician for guidance, especially if the child shows unusual symptoms like nausea or stomach pain.

Maintaining Safety in the Home

This incident serves as a reminder for families to periodically inspect all over-the-counter medications for changes in color, consistency, or the presence of unusual particles.

Local pharmacies in Mauldin, Simpsonville, and Fountain Inn are aware of the enforcement report and are working to ensure any remaining affected stock is removed from shelves. For many parents, especially those balancing busy schedules with school and extracurriculars, this recall emphasizes the importance of staying updated on FDA safety alerts.

The FDA continues to monitor the voluntary recall as Strides Pharma investigates the root cause of the contamination at its manufacturing facility.